Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Dysregulation of autophagy in the central nervous system of sheep naturally infected with classical scrapie

  • López-Pérez, Óscar
  • Otero, Alicia
  • Filali, Hicham
  • Sanz-Rubio, David
  • Toivonen, Janne M.
  • Zaragoza, Pilar
  • Badiola, Juan J.
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada
Autophagy is a dynamic cellular mechanism involved in protein and organelle turnover through lysosomal degradation. Autophagy regulation modulates the pathologies associated with many neurodegenerative diseases. Using sheep naturally infected with scrapie as a natural animal model of prion diseases, we investigated the regulation of autophagy in the central nervous system (CNS) during the clinical phase of the disease. We present a gene expression and protein distribution analysis of different autophagy-related markers and investigate their relationship with prion-associated lesions in several areas of the CNS. Gene expression of autophagy markers ATG5 and ATG9 was downregulated in some areas of scrapie brains. In contrast, ATG5 protein accumulates in medulla oblongata and positively correlates with prion deposition and scrapie-related lesions. The accumulation of this protein and p62, a marker of autophagy impairment, suggests that autophagy is decreased in the late phases of the disease. However, the increment of LC3 proteins and the mild expression of p62 in basal ganglia and cerebellum, primarily in Purkinje cells, suggests that autophagy machinery is still intact in less affected areas. We hypothesize that specific cell populations of the CNS may display neuroprotective mechanisms against prion-induced toxicity through the induction of PrPSc clearance by autophagy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility

  • Barrachina Porcar, Laura
  • Cequier Soler, Alina
  • Romero Lasheras, Antonio
  • Vitoria Moraiz, Arantza
  • Zaragoza Fernández, Pilar
  • Vázquez Bringas, Francisco José
  • Rodellar Penella, Clementina
Background Antibody production after allogeneic administration of mesenchymal stem cells (MSCs) could impact their clinical application. Proinflammatory priming of MSCs can potentiate their regulatory ability in vivo but increased expression of major histocompatibility complex (MHC) might augment their immunogenicity, potentially leading to immune memory thus limiting repeated allogeneic administration. This study aimed at evaluating the production of cytotoxic allo-antibodies directed against donor’s ELA (equine leukocyte antigen) in mismatched and halfmatched horses receiving repeated intraarticular administration of stimulated MSCs (MSC-primed) and unstimulated MSCs (MSC-naïve) in pathologic joints. Methods From available stored samples from a previous in vivo study, cells from one donor and serially collected sera (five time-points) from three groups of recipients were used based on their ELA haplotypes to perform microcytotoxicity assays: Group 1 recipients mismatched with the donor that received MSC-naïve (naïve-mismatched recipients); Group 2 recipients mismatched with the donor that received MSC-primed (primed-mismatched recipients); Group 3 recipients halfmatched with the donor (sharing 1/2 haplotypes) that received MSC-primed (primed-halfmatched recipients). Sera from recipients (neat, 1:2 and 1:16 dilution) were tested against target cells from the donor (cryopreserved and expanded MSC-naïve and MSC-primed) or from one animal presenting the same ELA haplotypes than the donor (fresh peripheral blood lymphocytes as control). Results One to three weeks after first MSC administration, all recipient groups produced allo-antibodies regardless of MSC received (naïve or primed) and matching degree with donor. However, secondary response after MSC re-exposure was less evident in halfmatched recipients (MSC-primed) than in mismatched ones (both MSC-naïve and MSC-primed). Recipients of MSC-primed (both mismatched and halfmatched) tended towards developing lower antibody response than MSC-naïve recipients in vivo, but MSC-primed were targeted to death in higher percentage in vitro in the microcytoxicity assay. Conclusions After first intraarticular allogeneic administration, the immunomodulatory profile of MSC-primed would have led to lower antibody production, but these antibodies would target more easily MSC-primed after second injection (re-exposure), likely because of their higher MHC expression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Impairment of autophagy in scrapie-infected transgenic mice at the clinical stage

  • López-Pérez, Óscar
  • Toivonen, Janne Markus
  • Otero, Alicia
  • Solanas, Laura
  • Zaragoza, Pilar
  • Badiola, Juan José
  • Osta, Rosario
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada
Autophagy appears to play a role in the etiology and progress of misfolded protein disorders. Although this process is dysregulated in prion diseases, it is unknown whether this impairment is a cause or a consequence of prion neuropathology. The study of autophagy during the progress of the disease could elucidate its role. For this purpose, we have investigated its regulation at different stages of the disease in Tg338 mice, a transgenic murine model that overexpresses the highly susceptible ovine VRQ prion protein allele. Mice were intracerebrally inoculated with mouse adapted classical scrapie and euthanized at the preclinical and clinical stages of the disease. Regulation of autophagy was investigated analyzing the distribution of LC3-B and p62 proteins by immunohistochemistry. Moreover, the expression of genes involved in autophagy regulation was quantified by real-time PCR. LC3-B and p62 proteins were downregulated and upregulated, respectively, in the central nervous system of infected mice with clinical signs of scrapie. Accumulation of p62 correlated with scrapierelated lesions, suggesting an impairment of autophagy in highly prion-affected areas. In addition, Gas5 (growth arrestspecific 5), Atg5 (autophagy-related 5), and Fbxw7 (F-box and WD repeat domain containing 7) transcripts were downregulated in mesencephalon and cervical spinal cord of the same group of animals. The impairment of autophagic machinery seems to be part of the pathological process of scrapie, but only during the late stage of prion infection. Similarities between Tg338 mice and the natural ovine disease make them a reliable in vivo model to study prion infection and autophagy side by side.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Forkhead Box P3 Methylation and Expression in Men with Obstructive Sleep Apnea

  • Sanz-Rubio, David
  • Sanz, Arianne
  • Varona, Luis
  • Bolea, Rosa
  • Forner, Marta
  • Gil, Aana V.
  • Cubero, Pablo
  • Marin-Oto, Marta
  • Martin-Burriel, Inmaculada
  • Marin, José M.
BACKGROUND: Epigenetic changes in obstructive sleep apnea (OSA) have been proposed as a mechanism for end-organ vulnerability. In children with OSA, Forkhead Box P3 (FOXP3) DNA methylation were associated with inflammatory biomarkers; however, the methylation pattern and its effect in the expression of this gene have not been tested in adults with OSA. METHODS: Plasma samples from subjects without comorbid conditions other than OSA were analyzed (the Epigenetics Status and Subclinical Atherosclerosis in Obstructive Sleep Apnea (EPIOSA) Study: NCT02131610). In 16 patients with severe OSA (Apnea-Hypopnea Index-AHI- > 30 events/h) and seven matched controls (AHI < 5), methylation of FOXP3 gen was evaluated by PCR of the promoter and by pyrosequencing of the intron 1 Treg-specific demethylated region (TSDR). In another 74 patients with OSA (AHI > 10) and 31 controls, we quantified FOXP3 protein expression by ELISA and gene expression by quantitative real-time PCR. C-reactive protein (CRP) and plasma Treg cells were also evaluated. RESULTS: Neither the levels of the promoter nor the TSDR demethylated region were different between controls and patients with OSA, whether they were grouped by normal or high CRP. FOXP3 protein and mRNA expression did not differ between groups. CONCLUSIONS: FOXP3 methylation or its expression is not altered in adults with OSA, whatever their inflammatory status.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Bambi and chga in prion diseases: neuropathological assessment and potential role as disease biomarkers

  • López-Pérez, Óscar
  • Bernal-Martín, Marcos
  • Hernaiz, Adelaida
  • Llorens, Franc
  • Betancor, Marina
  • Otero,Alicia
  • Toivonen, Janne Markus
  • Zaragoza, Pilar
  • Zerr, Inga
  • Badiola, Juan José
  • Bolea, Rosa
  • Martín-Burriel, Inmaculada.
Prion diseases affect both animals and humans. Research in the natural animal model of the disease could help in the understanding of neuropathological mechanisms and in the development of biomarkers for human pathologies. For this purpose, we studied the expression of 10 genes involved in prion propagation in vitro in the central nervous system of scrapie-infected sheep. Dysregulated genes (BAMBI and CHGA) were further analysed in a transgenic murine model (Tg338) of scrapie, and their protein distribution was determined using immunohistochemistry and Western blot. Their potential as biomarkers was finally assessed using enzyme-linked immunosorbent assay (ELISA) in cerebrospinal fluid (CSF) of scrapie sheep and Creutzfeldt-Jakob disease (CJD) patients. Protein BAMBI was upregulated in highly affected brain areas and CHGA was overexpressed along the brain in both models. Moreover, BAMBI and CHGA immunostaining scores strongly correlated with spongiosis and microgliosis in mice. Finally, levels of BAMBI were significantly higher in the CSF of clinical sheep and CJD patients. In addition to their potential as biomarkers, our work confirms the role of BAMBI and CHGA in prion neuropathology in vivo, but besides prion replication, they seem to be involved in the characteristic neuroinflammatory response associated to prion infection. Las enfermedades priónicas afectan tanto a los animales como a los humanos. La investigación en el modelo animal natural de la enfermedad podría ayudar en la comprensión de los mecanismos neuropatológicos y en el desarrollo de biomarcadores para patologías humanas. Para ello, estudiamos la expresión de 10 genes implicados en la propagación de priones in vitro en el sistema nervioso central de ovejas infectadas con scrapie. Genes desregulados ( BAMBI y CHGA) se analizaron más a fondo en un modelo murino transgénico (Tg338) de tembladera, y su distribución de proteínas se determinó mediante inmunohistoquímica y transferencia Western. Finalmente, se evaluó su potencial como biomarcadores utilizando un ensayo inmunoabsorbente ligado a enzimas (ELISA) en líquido cefalorraquídeo (LCR) de ovejas con tembladera y pacientes con enfermedad de Creutzfeldt-Jakob (ECJ). La proteína BAMBI se reguló positivamente en áreas cerebrales muy afectadas y CHGA se sobreexpresó a lo largo del cerebro en ambos modelos. Además, las puntuaciones de inmunotinción de BAMBI y CHGA se correlacionaron fuertemente con la espongiosis y la microgliosis en ratones. Finalmente, los niveles de BAMBI fueron significativamente más altos en el líquido cefalorraquídeo de ovejas clínicas y pacientes con ECJ. Además de su potencial como biomarcadores, nuestro trabajo confirma el papel de BAMBI y CHGA en la neuropatología priónica in vivo, pero además de la replicación priónica,
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

  • Toivonen, Janne M.
  • Sanz-Rubio, David
  • López-Pérez, Óscar
  • Marín-Moreno, Alba
  • Bolea, Rosa
  • Osta, Rosario
  • Badiola, Juan J.
  • Zaragoza, Pilar
  • Espinosa, Juan Carlos
  • Torres, Juan María
  • Martín-Burriel, Inmaculada
MicroRNAs (miRNAs) may contribute to the development and pathology of many neurodegenerative diseases, including prion diseases. They are also promising biomarker candidates due to their stability in body fluids. We investigated miRNA alterations in a Tg501 mouse model of prion diseases that expresses a transgene encoding the goat prion protein (PRNP). Tg501 mice intracranially inoculated with mouse-adapted goat scrapie were compared with age-matched, mock inoculated controls in preclinical and clinical stages. Small RNA sequencing from the cervical spinal cord indicated that miR-223-3p, miR-151-3p, and miR-144-5p were dysregulated in scrapie-inoculated animals before the onset of symptoms. In clinical-stage animals, 23 significant miRNA alterations were found. These miRNAs were predicted to modify the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways including prion disease, extracellular matrix interactions, glutaminergic synapse, axon guidance, and transforming growth factor-beta signaling. MicroRNAs miR-146a-5p (up in cervical spinal cord) and miR-342-3p (down in cervical spinal cord, cerebellum and plasma), both indicated in neurodegenerative diseases earlier, were verified by quantitative real-time polymerase chain reaction (qRT-PCR). Minimal changes observed before the disease onset suggests that most miRNA alterations observed here are driven by advanced prion-associated pathology, possibly limiting their use as diagnostic markers. However, the results encourage further mechanistic studies on miRNA-regulated pathways involved in these neurodegenerative conditions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The genetic ancestry of American Creole cattle inferred from uniparental and autosomal genetic markers

  • Ginja, Catarina
  • Gama, Luis Telo
  • Cortés, Oscar
  • Martín Burriel, Inmaculada
  • Vega-Pla, Jose Luis
  • Penedo, Cecilia
  • Sponenberg, Phil
  • Cañón, Javier
  • Sanz, Arianne
  • do Egito, Andrea Alves
  • Alvarez, Luz Angela
  • Giovambattista, Guillermo
  • Agha, Saif
  • Rogberg-Muñoz, Andrés
  • Lara, Maria Aparecida Cassiano
  • Afonso, Sónia
  • Aguirre, Lenin
  • Armstrong, Eileen
  • Vallejo, Maria Esperanza Camacho
  • Canales, Amado
  • Cassamá, Bernardo
  • Contreras, Gloria
  • Cordeiro, J. M. Moras
  • Dunner, Susana
  • Elbeltagy, Ahmed
  • Fioravanti, Maria Clorinda Soares
  • Carpio, Mayra Gómez
  • Gómez, Mariano
  • Hernández, Antonio
  • Hernandez, Darwin
  • Juliano, Raquel Soares
  • Landi, Vincenzo
  • Marques, Ribamar
  • Martínez, Rubén D.
  • Martínez, O. Roberto
  • Melucci, Lilia
  • Flores, Baldomero Molina
  • Mújica, Fernando
  • Parés i Casanova, Pere-Miquel
  • Quiroz, Jorge
  • Rodellar, Clementina
  • Tjon, Gerald
  • Adebambo, Tumininu
  • Uffo, Odalys
  • Vargas, Julio César
  • Villalobos, Axel
  • Zaragoza, Pilar
  • Delgado, Juan Vicente
  • Martinez, Amparo
Cattle imported from the Iberian Peninsula spread throughout America in the early years of discovery and colonization to originate Creole breeds, which adapted to a wide diversity of environments and later received influences from other origins, including zebu cattle in more recent years. We analyzed uniparental genetic markers and autosomal microsatellites in DNA samples from 114 cattle breeds distributed worldwide, including 40 Creole breeds representing the whole American continent, and samples from the Iberian Peninsula, British islands, Continental Europe, Africa and American zebu. We show that Creole breeds differ considerably from each other, and most have their own identity or group with others from neighboring regions. Results with mtDNA indicate that T1c-lineages are rare in Iberia but common in Africa and are well represented in Creoles from Brazil and Colombia, lending support to a direct African influence on Creoles. This is reinforced by the sharing of a unique Y-haplotype between cattle from Mozambique and Creoles from Argentina. Autosomal microsatellites indicate that Creoles occupy an intermediate position between African and European breeds, and some Creoles show a clear Iberian signature. Our results confirm the mixed ancestry of American Creole cattle and the role that African cattle have played in their development.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Otros (Other)

Author Correction: The genetic ancestry of American Creole cattle inferred from uniparental and autosomal genetic markers (Scientific Reports, (2019), 9, 1, (11486), 10.1038/s41598-019-47636-0)

  • Ginja, Catarina
  • Gama, Luis Telo
  • Cortés, Oscar
  • Martín Burriel, Inmaculada
  • Vega-Pla, Jose Luis
  • Penedo, Cecilia
  • Sponenberg, Phil
  • Cañón, Javier
  • Sanz, Arianne
  • do Egito, Andrea Alves
  • Alvarez, Luz Angela
  • Giovambattista, Guillermo
  • Agha, Saif
  • Rogberg-Muñoz, Andrés
  • Lara, Maria Aparecida Cassiano
  • Afonso, Sónia
  • Aguirre, Lenin
  • Armstrong, Eileen
  • Vallejo, Maria Esperanza Camacho
  • Canales, Amado
  • Cassamá, Bernardo
  • Contreras, Gloria
  • Cordeiro, J. M. Moras
  • Dunner, Susana
  • Elbeltagy, Ahmed
  • Fioravanti, Maria Clorinda Soares
  • Carpio, Mayra Gómez
  • Gómez, Mariano
  • Hernández, Antonio
  • Hernandez, Darwin
  • Juliano, Raquel Soares
  • Landi, Vincenzo
  • Marques, Ribamar
  • Martínez, Rubén D.
  • Martínez, O. Roberto
  • Melucci, Lilia
  • Flores, Baldomero Molina
  • Mújica, Fernando
  • Parés i Casanova, Pere-Miquel
  • Quiroz, Jorge
  • Rodellar, Clementina
  • Tjon, Gerald
  • Adebambo, Tumininu
  • Uffo, Odalys
  • Vargas, Julio César
  • Villalobos, Axel
  • Zaragoza, Pilar
  • Delgado, Juan Vicente
  • Martinez, Amparo
Correction to: Scientific Reports https ://doi.org/10.1038/s4159 8-019-47636 -0, published online 07 August 2019 This Article contains errors. The Acknowledgements section in this Article is incomplete, the funding source LISBOA-01-0145-FEDER-016647 is omitted, “This work was supported by Animal Breeding Consulting S.L., Córdoba, Spain. This work was partially funded by the Veterinary Genetics Laboratory, University of California, Davis, VELOGEN S.L., Madrid, Spain and by Grupo de Referencia A19-17R LAGENBIO from Gobierno de Aragon/Fondo Social Europeo. C.G. was supported by Fundação Nacional para a Ciência e a Tecnologia (FCT), Portugal, Investigador FCT Grant IF/00, 866/2014, and Project grant PTDC/CVTLIV/2827/2014 co-funded by COMPETE 2020 POCI-01-0145-FEDER-016647. The authors thank the collaboration of breeders, breed associations and “Red Iberoamericana Sobre la Conservacion de la Biodiversidad de Animales Domesticos Locales para el Desarollo Rural Sostenible (Red CONBIAND)” for the sharing of biological samples. Members of the CYTED XII-H and CONBIAND networks are thanked for valuable cooperation over the years. Authors thank Juan Antonio Pereira (FCV-UAGRM, Bolivia) and Olivier Hanotte for their support with sampling Criollo Yacumeño and Eastern Shorthorn Zebu respectively.” should read: “This work was supported by Animal Breeding Consulting S.L., Córdoba, Spain. This work was partially funded by the Veterinary Genetics Laboratory, University of California, Davis, VELOGEN S.L., Madrid, Spain and by Grupo de Referencia A19-17R LAGENBIO from Gobierno de Aragon/Fondo Social Europeo. C.G. was supported by Fundação Nacional para a Ciência e a Tecnologia (FCT), Portugal, Investigador FCT Grant IF/00, 866/2014, Project grant PTDC/CVTLIV/2827/2014 co-funded by COMPETE 2020 POCI-01-0145-FEDER-016647 and LISBOA-01-0145-FEDER-016647. The authors thank the collaboration of breeders, breed associations and “Red Iberoamericana Sobre la Conservacion de la Biodiversidad de Animales Domesticos Locales para el Desarollo Rural Sostenible (Red CONBIAND)” for the sharing of biological samples. Members of the CYTED XII-H and CONBIAND networks are thanked for valuable cooperation over the years. Authors thank Juan Antonio Pereira (FCV-UAGRM, Bolivia) and Olivier Hanotte for their support with sampling Criollo Yacumeño and Eastern Shorthorn Zebu, respectively.” In addition, a Data Availability section is not included in the article – it should appear as below: “Data availability STR data used in our analysis is available in the Dryad repository: https :; doi.org/10.5061/dryad .5dv41 ns43”.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid and plasma small extracellular vesicles and mirnas as biomarkers for prion diseases

  • López-Pérez, Óscar
  • Sanz-Rubio, David
  • Hernaiz, Adelaida
  • Betancor, Marina
  • Otero, Alicia
  • Castilla, Joaquín
  • Andréoletti, Olivier
  • Badiola, Juan José
  • Zaragoza, Pilar
  • Bolea, Rosa
  • Toivonen, Janne
  • Martín-Burriel, Inmaculada
Diagnosis of transmissible spongiform encephalopathies (TSEs), or prion diseases, is based on the detection of proteinase K (PK)-resistant PrPSc in post-mortem tissues as indication of infection and disease. Since PrPSc detection is not considered a reliable method for in vivo diagnosis in most TSEs, it is of crucial importance to identify an alternative source of biomarkers to provide useful alternatives for current diagnostic methodology. Ovine scrapie is the prototype of TSEs and has been known for a long time. Using this natural model of TSE, we investigated the presence of PrPSc in exosomes derived from plasma and cerebrospinal fluid (CSF) by protein misfolding cyclic amplification (PMCA) and the levels of candidate microRNAs (miRNAs) by quantitative PCR (qPCR). Significant scrapie-associated increase was found for miR-21-5p in plasma-derived but not in CSF-derived exosomes. However, miR-342-3p, miR-146a-5p, miR-128-3p and miR-21-5p displayed higher levels in total CSF from scrapie-infected sheep. The analysis of overexpressed miRNAs in this biofluid, together with plasma exosomal miR-21-5p, could help in scrapie diagnosis once the presence of the disease is suspected. In addition, we found the presence of PrPSc in most CSF-derived exosomes from clinically affected sheep, which may facilitate in vivo diagnosis of prion diseases, at least during the clinical stage.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Equine mesenchymal stem cells influence the proliferative response of lymphocytes: effect of inflammation, differentiation and MHC-compatibility

  • Cequier, Alina
  • Romero, Antonio
  • Vázquez, Francisco J.
  • Vitoria, Arantza
  • Bernad, Elvira
  • Fuente, Sara
  • Zaragoza, Pilar
  • Rodellar, Clementina
  • Barrachina, Laura
Immunomodulation and immunogenicity are pivotal aspects for the therapeutic use of mesenchymal stem cells (MSCs). Since the horse is highly valuable as both a patient and translational model, further knowledge on equine MSC immune properties is required. This study analysed how inflammation, chondrogenic differentiation and compatibility for the major histocompatibility complex (MHC) influence the MSC immunomodulatory–immunogenicity balance. Equine MSCs in basal conditions, pro-inflammatory primed (MSC-primed) or chondrogenically differentiated (MSC-chondro) were co-cultured with either autologous or allogeneic MHC-matched/mismatched lymphocytes in immune-suppressive assays (immunomodulation) and in modified one-way mixed leukocyte reactions (immunogenicity). After co-culture, frequency and proliferation of T cell subsets and B cells were assessed by flow cytometry and interferon-ɣ (IFNɣ) secretion by ELISA. MSC-primed showed higher regulatory potential by decreasing proliferation of cytotoxic and helper T cells and B cells. However, MHC-mismatched MSC-primed can also activate lymphocytes (proliferative response and IFNɣ secretion), likely due to increased MHC-expression. MSC-chondro maintained their regulatory ability and did not increase their immunogenicity, but showed less capacity than MSC-primed to induce regulatory T cells and further stimulated B cells. Subsequent in vivo studies are needed to elucidate the complex interactions between MSCs and the recipient immune system, which is critical to develop safe and effective therapies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The immunomodulation–immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility

  • Cequier, Alina
  • Vázquez, Francisco José
  • Romero, Antonio
  • Vitoria, Arantza
  • Bernad, Elvira
  • García-Martínez, Mirta
  • Gascón, Isabel
  • Barrachina, Laura
  • Rodellar, Clementina
The immunomodulatory properties of equine mesenchymal stem cells (MSCs) are important for their therapeutic potential and for their facilitating role in their escape from immune recognition, which may also be influenced by donor–recipient major histocompatibility complex (MHC) matching/mismatching and MHC expression level. Factors such as inflammation can modify the balance between regulatory and immunogenic profiles of equine MSCs, but little is known about how the exposure to the immune system can affect these properties in equine MSCs. In this study, we analyzed the gene expression and secretion of molecules related to the immunomodulation and immunogenicity of equine MSCs, either non-manipulated (MSC-naive) or stimulated by pro-inflammatory cytokines (MSC-primed), before and after their exposure to autologous or allogeneic MHC-matched/-mismatched lymphocytes, either activated or resting. Cytokine priming induced the immunomodulatory profile of MSCs at the baseline (MSCs cultured alone), and the exposure to activated lymphocytes further increased the expression of interleukin 6 (IL6), cyclooxygenase 2, and inducible nitric oxide synthase, and IL6 secretion. Activated lymphocytes were also able to upregulate the regulatory profile of MSC-naive to levels comparable to cytokine priming. On the contrary, resting lymphocytes did not upregulate the immunomodulatory profile of equine MSCs, but interestingly, MSC-primed exposed to MHC-mismatched lymphocytes showed the highest expression and secretion of these mediators, which may be potentially linked to the activation of lymphocytes upon recognition of foreign MHC molecules. Cytokine priming alone did not upregulate the immunogenic genes, but MSC-primed exposed to activated or resting lymphocytes increased their MHC-I and MHC-II expression, regardless of the MHC-compatibility. The upregulation of immunogenic markers including CD40 in the MHC-mismatched co-culture might have activated lymphocytes, which, at the same time, could have promoted the immune regulatory profile aforementioned. In conclusion, activated lymphocytes are able to induce the equine MSC regulatory profile, and their effects seem to be additive to the priming action. Importantly, our results suggest that the lymphocyte response against MHC-mismatched MSC-primed would promote further activation of their immunomodulatory ability, which eventually might help them evade this reaction. Further studies are needed to clarify how these findings might have clinical implications in vivo, which will help developing safer and more effective therapies.